Spine Biologics Market to Surpass USD 3.5 billion in 2033, e

Wilmington, Delaware, United States, June 19, 2023 (GLOBE NEWSWIRE) -- The global spine biologics market is anticipated to be valued at US$ 3.5 billion by 2031, expected to incline at a CAGR of 4.2% from 2023 to 2031.

Related Keywords

Japan , Canada , India , Australia , Delaware , United States , China , America , American , Asia Pacific , Nikhil Sawlani , Johnson Depuy Synthes , Zimmer Biomet , Transparency Market Research , Surgery Centers , Research Solutions , Nuvasive Inc , Human Research Ethics Committee , Arthrex Inc , Exactech Inc , Bone Biologics Corporation , Transparency Market Research Inc , Medtronic , Hippofi Inc , Orthofix Medical Inc , Stryker Corporation , Spine Wave Inc , Medtronic Plc , Biologics Hippofi Inc , American Association Of Neurological Surgeons , Specific Research Solutions , Biologics Market , Prominent Growth , North America , American Association , Neurological Surgeons , Depuy Synthes , Orthofix Medical , Bone Matrix , Market Research , Canada Toll Free ,